Background Multipotent mesenchymal stromal cells ( MSC) have become important tools in regenerative and transplantation medicine. Rapidly increasing numbers of patients are receiving in vitro-expanded MSC. Culture conditions typically include FSC because human serum does not fully support growth of human MSC in vitro (MSCFCS). Concerns regarding BSE, other infectious complications and host immune reactions have fueled investigation of alternative culture supplements. Methods As PDGF has long been identified as a growth factor for MSC, we tested media supplementation with platelet lysate for support of MSC proliferation. Results We found that primary cultures of BM-derived MSC can be established with animal serum-free media containing fresh frozen plasma and platelets (MSCFFPP). Moreover, MSCFFPP showed vigorous proliferation that was superior to classical culture conditions containing FCS. MSCFFPP morphology was equivalent to MSC FCS, and MSCFFPP expressed CD73, CD90, CD105, CD106, CD146 and HLA-ABC while being negative for CD34, CD45 and surface HLA-DR, as expected. In addition to being phenotypically identical, MSCFFPP could efficiently differentiate into adipocytes and osteoblasts. In terms of immune regulatory properties, MSCFFPP were indistinguishable from MSC FCS. Proliferation of PBMC induced by IL-2 in combination with OKT-3 or by PHA was inhibited in the presence of MSCFFPP. Discussion Taken together, FCS can be replaced safely by FFPP in cultures of MSC for clinical purposes.

Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM / I., Muller; S., Kordowich; C., Holzwarth; Spano, Maria Carlotta; G., Isensee; A., Staiber; S., Viebahn; F., Gieseke; H., Langer; Mp, Gawaz; Em, Horwitz; Conte, Pierfranco; R., Handgretinger; Dominici, Massimo. - In: CYTOTHERAPY. - ISSN 1465-3249. - STAMPA. - 8:5(2006), pp. 437-444. [10.1080/14653240600920782]

Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM

SPANO, Maria Carlotta;CONTE, Pierfranco;DOMINICI, Massimo
2006

Abstract

Background Multipotent mesenchymal stromal cells ( MSC) have become important tools in regenerative and transplantation medicine. Rapidly increasing numbers of patients are receiving in vitro-expanded MSC. Culture conditions typically include FSC because human serum does not fully support growth of human MSC in vitro (MSCFCS). Concerns regarding BSE, other infectious complications and host immune reactions have fueled investigation of alternative culture supplements. Methods As PDGF has long been identified as a growth factor for MSC, we tested media supplementation with platelet lysate for support of MSC proliferation. Results We found that primary cultures of BM-derived MSC can be established with animal serum-free media containing fresh frozen plasma and platelets (MSCFFPP). Moreover, MSCFFPP showed vigorous proliferation that was superior to classical culture conditions containing FCS. MSCFFPP morphology was equivalent to MSC FCS, and MSCFFPP expressed CD73, CD90, CD105, CD106, CD146 and HLA-ABC while being negative for CD34, CD45 and surface HLA-DR, as expected. In addition to being phenotypically identical, MSCFFPP could efficiently differentiate into adipocytes and osteoblasts. In terms of immune regulatory properties, MSCFFPP were indistinguishable from MSC FCS. Proliferation of PBMC induced by IL-2 in combination with OKT-3 or by PHA was inhibited in the presence of MSCFFPP. Discussion Taken together, FCS can be replaced safely by FFPP in cultures of MSC for clinical purposes.
2006
8
5
437
444
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM / I., Muller; S., Kordowich; C., Holzwarth; Spano, Maria Carlotta; G., Isensee; A., Staiber; S., Viebahn; F., Gieseke; H., Langer; Mp, Gawaz; Em, Horwitz; Conte, Pierfranco; R., Handgretinger; Dominici, Massimo. - In: CYTOTHERAPY. - ISSN 1465-3249. - STAMPA. - 8:5(2006), pp. 437-444. [10.1080/14653240600920782]
I., Muller; S., Kordowich; C., Holzwarth; Spano, Maria Carlotta; G., Isensee; A., Staiber; S., Viebahn; F., Gieseke; H., Langer; Mp, Gawaz; Em, Horwitz; Conte, Pierfranco; R., Handgretinger; Dominici, Massimo
File in questo prodotto:
File Dimensione Formato  
Muller I et al. MSC and PLTs Cytotherapy 2006.pdf

Solo gestori archivio

Tipologia: Versione pubblicata dall'editore
Dimensione 382.33 kB
Formato Adobe PDF
382.33 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/303909
Citazioni
  • ???jsp.display-item.citation.pmc??? 65
  • Scopus 214
  • ???jsp.display-item.citation.isi??? 190
social impact